In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
If you have received an emergency alert on your phone today i.e. on July 20, then you do not need
The Indian team, which was undefeated so far in the World Cup, got two days' rest after the match
For the last two days, there is a bearish atmosphere in the Indian stock market, due to which the
If you are also planning to invest in cryptocurrency or digital currency, then today is your best
After the violence on July 31, the administration is working day and night to bring the situation
India saved 35 thousand crores by buying oil from Russia, and US-Europe objected
Recently, the meeting of Prime Minister Narendra Modi and Russian President Vladimir Putin in Sam
Sheikh Rashid, the big-hearted minister of the Imran government of Pakistan, has become a problem
The government has made it clear that it is not considering enacting a population control law in
People have come on the road against the zero covid policy in China. These demonstrations, which
BSF has joined the fleet of three new floating border out-post ships, ready in the country
On one hand, on Wednesday, where the 73rd Republic Day was celebrated with great pomp in the coun
